Professor Tim Hughes is an internationally renowned haematologist and cancer researcher.

He's led many key global and national trials throughout his extensive career, perhaps most notably being heavily involved in the testing of Asciminib, a modern tyrosine kinase inhibitor capable of reducing the burden of disease in chronic myeloid leukaemia (CML) to zero, and in some cases, allowing patients to live in treatment-free remission.

Tim is also an avid hiker, having summited both Mount Kilimanjaro in Tanzania and Annapurna in Nepal to raise money for CML research through Climb for a Cure.